retatrutide ada 2025 results Highlights: A New Era for GLP-1 Therapies in Obesity and Diabetes Retatrutide approval: FDA status, clinical

Granata A, Maccarrone R, Anzaldi M, Leonardi G, Pesce F, Amico F, et al (2022) GLP-1 receptor agonists and renal outcomes in patients with diabetes mellitus type 2 and diabetic kidney disease: State of the art

So, prioritize getting 7-10 hours of the best quality sleep possible

"With Mounjaro, between the weight loss and the health improvement, I feel like I am able to connect to my physical self." After months of being unable to see her weight loss, Casselman says she's ready to confront the in-laws' mirror and begin to begin to accept her new, changing body

The FDA advises against using compounded versions unless approved medications are not available or you cannot tolerate the approved medication

So far loving it